What SYNLAB does

SYNLAB Provence is the largest French subsidiary of the SYNLAB Group, which is described in the source material as the European leader in medical diagnostics. Operating as a network of 66 medical biology laboratories across three southeastern French departments (Bouches-du-Rhône with 55 sites, Vaucluse with 7, and Alpes de Haute-Provence with 4), the company provides comprehensive clinical diagnostic services to individual patients and referring healthcare professionals. Its service portfolio spans routine clinical biology (blood tests, urine analysis, gynecological sampling, COVID testing), specialty diagnostics including genetic testing (SYNLAB Génétique France), cancer diagnostics through anatomo-cyto-pathology, functional and nutritional biology, cardiovascular screening, infectious disease testing (including tick-borne illnesses such as Lyme), reproductive medicine support (Assistance Médicale à la Procréation), and mental health screening via the myEDIT-B blood test for distinguishing depression from bipolar disorder. The network processes approximately 6,000 patients per day excluding COVID activity.

The underlying operating model combines a distributed physical footprint for sample collection with 8 centralized technical platforms and 4 medical excellence poles for high-volume processing. SYNLAB Provence holds NF EN ISO 15189 accreditation (n°8-1906) issued by COFRAC, ensuring compliance with international quality standards for medical laboratories. Patient-facing technology is delivered through the mySYNLAB online portal, which provides multilingual result access, appointment scheduling, and home sample collection requests. The recently introduced myEDIT-B test, developed by Alcediag and reported at approximately 83% accuracy in clinical trials, represents the company's most differentiated proprietary offering, applied across France, Switzerland, and Italy.

SYNLAB Provence operates a direct-to-consumer go-to-market with a transaction-based revenue model. Patients access services either through physician referrals or directly at walk-in laboratory sites, with standard diagnostic tests reimbursed by the French national health insurance system (Sécurité Sociale) subject to standard co-payments. Revenue is generated on a per-test basis, with the 6,000-patient-daily throughput providing high-volume recurring transactional revenue. A secondary B2B layer supports healthcare professionals and referring physicians through a dedicated professional portal, continuous biological information updates, and continuing education through the SYNLAB Academy, including an 8-module Functional and Nutritional Biology program. Workforce scale comprises approximately 550 collaborators, including 70 medical biologists (doctors and pharmacists).

Name

SYNLAB

Legal name

SYNLAB

Website

https://provence.synlab.fr

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

SYNLAB Provence operates 66 medical biology laboratories across southeastern France, serving approximately 6,000 patients daily with routine and specialty diagnostics, including genetics, cancer pathology, and the proprietary myEDIT-B mental health blood test.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)

Keywords

• Medical diagnostic services
• Clinical laboratory testing
• Pathology diagnostics
• Genetic testing services
• Health screening

Headquarters

HQ city

Marseille

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Clinical Laboratory Testing Services: SYNLAB generates revenue through providing medical diagnostic testing services directly to patients. Services are covered by French national health insurance (Sécurité Sociale) for standard tests, with patients typically paying co-pays. The network processes approximately 6000 patients per day, generating recurring transaction-based revenue from each test performed.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

SYNLAB operates a network of medical diagnostic laboratories providing clinical biology testing, including routine blood and urine analysis, infectious disease screening, genetic testing, cancer pathology, reproductive health diagnostics, and specialized mental health blood tests. Services are delivered through physical lab locations and home sampling, with results accessible via an online patient portal, and are largely reimbursed by French national health insurance (Sécurité Sociale).

Product overview

SYNLAB operates a network of medical analysis laboratories offering comprehensive diagnostic services across multiple specialties. The portfolio includes core laboratory testing services (blood tests, urinalysis, STI screening, Covid testing), specialized diagnostic services (cardiovascular, genetics, cancer diagnostics, infectious diseases, reproductive assistance), and the myEDIT-B mental health blood test for bipolar disorder differentiation. SYNLAB provides patient-facing digital access through mySYNLAB portal for results viewing and appointment management, with 66 laboratories across southern France serving approximately 6,000 patients daily.

Differentiator

Problem solved

Functional benefit

Brands

• mySYNLAB: Patient portal for accessing test results online
• myEDIT-B

Products and services

• Medical Analysis Services Comprehensive medical laboratory testing services including blood tests, urine tests, gynecological tests, mycological and bacteriological samples, Covid testing, and specialized diagnostics for patients and referring physicians.
• STI Testing (IST) Free STI screening services detecting HIV, hepatitis B, syphilis, chlamydia, and gonorrhea, available without prescription at SYNLAB laboratories.
• myEDIT-B Mental Health Test Blood test for distinguishing between depression and bipolar disorder, developed by Alcediag, with approximately 83% clinical accuracy. Available in France, Switzerland, and Italy as a diagnostic aid for psychiatrists.
• mySYNLAB Patient Portal Online platform allowing patients to access their analysis results after validation by a biologist, with multilingual support and appointment scheduling capabilities.
• Women's Health Services Specialized diagnostic services for women's health including gynecological testing, reproductive assistance (AMP), and related screening services.
• Cardiovascular Diagnostics Cardiovascular disease screening and early detection services.
• Functional and Nutritional Biology (BFN) Functional biology testing services focusing on nutrition and metabolic function assessment, including training programs for healthcare professionals.
• Medical Genetics Genetic testing and analysis services for medical diagnosis purposes.
• Cancer Diagnostics Anatomopathology and cytology services for cancer diagnosis and monitoring.
• Infectious Disease Testing Diagnosis and testing services for infectious diseases including tick-borne illnesses such as Lyme disease.
• Reproductive Assistance (AMP) Medical assistance for reproduction including diagnostic testing for fertility and assisted reproductive technology support.
• Home Sampling Services At-home sample collection services for patients unable to visit laboratories, including urine samples for infants and children.

Quantifiable outcome

• 6000 patients served daily
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Cerba HealthCare: Major French clinical and specialty diagnostics operator with national coverage including routine biology, reference testing, and clinical trial central lab services. Directly comparable as another scaled multi-site French clinical lab network competing for the same patients, physicians, and reimbursement flows.
• INOVIE: French multi-site clinical laboratory operator (formed from the merger of several regional lab groups) offering routine and specialty diagnostics. Comparable on branch density in France and revenue model via Sécurité Sociale reimbursement.
• Biogroup: Large French clinical biology laboratory network serving patients and physicians across multiple regions. Closest direct competitor on multi-site routine diagnostic testing within France with similar GTM through walk-in collection sites.
• Laborizon: Regional French clinical biology laboratory group serving patients and physicians. Comparable as another branch-network French lab operator competing for local catchment volume.
• Unilabs: European clinical laboratory group with substantial French footprint offering routine and specialty diagnostics. Competes with SYNLAB Provence across both patient-direct testing and physician-referred specialty work.
• Eurofins Genoma (Eurofins Clinical Diagnostics France): Eurofins' clinical diagnostics arm operating in France with a network of patient collection centers and specialty testing (genetics, reproductive medicine). Directly comparable routine and specialty clinical diagnostics operator with national French presence.

Broad incumbents

• Labcorp (Laboratory Corporation of America): Large global clinical laboratory network with central lab services and specialty diagnostics. Comparable on clinical testing menu and physician referral model, but operates at much greater scale and primarily in North America.
• Quest Diagnostics: Major US-headquartered clinical laboratory operator with broad routine and specialty diagnostics across consumer, physician, and employer channels. Comparable business model and test menu; represents the US analogue of SYNLAB Provence's services.

Others

• bioMérieux: French-headquartered in vitro diagnostics manufacturer supplying microbiology, immunoassays, and molecular diagnostics to clinical laboratories including competitors of SYNLAB Provence. Comparable as an adjacent stakeholder in the French diagnostics value chain.
• Roche Diagnostics: Global diagnostics manufacturer offering instruments, reagents, and assays (including genetic and oncology testing) used by clinical labs such as SYNLAB Provence. Comparable as an enabling technology supplier and overlap on specialty menu areas.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/SYNLABProvence
• LinkedInlinkedin.com/company/synlab-provence
• Instagraminstagram.com/synlabprovence

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SYNLAB